Pieraccioli, Marco
 Distribuzione geografica
Continente #
EU - Europa 149
NA - Nord America 88
AS - Asia 56
Totale 293
Nazione #
US - Stati Uniti d'America 87
IT - Italia 81
SG - Singapore 26
CN - Cina 19
SE - Svezia 15
DE - Germania 11
FR - Francia 10
IE - Irlanda 10
ID - Indonesia 8
RU - Federazione Russa 6
NL - Olanda 5
AT - Austria 3
CH - Svizzera 2
CZ - Repubblica Ceca 2
FI - Finlandia 2
CA - Canada 1
GB - Regno Unito 1
IN - India 1
MY - Malesia 1
TR - Turchia 1
UA - Ucraina 1
Totale 293
Città #
Rome 40
Singapore 24
Ashburn 18
Chandler 16
Milan 13
Dublin 10
Beijing 8
Jakarta 8
Marseille 8
New York 8
Chicago 7
Munich 6
Amsterdam 5
Hangzhou 4
Moscow 4
Busto Arsizio 3
Irvine 3
Mugnano di Napoli 3
Vienna 3
Bari 2
Boston 2
Brno 2
Clifton 2
Cosenza 2
Lappeenranta 2
Nuremberg 2
Palermo 2
San Martino Valle Caudina 2
Bern 1
Boardman 1
Chengdu 1
Cormons 1
Fairfield 1
Frankfurt am Main 1
Kuala Lumpur 1
Los Angeles 1
Molfetta 1
Mondragone 1
Monza 1
Mumbai 1
Phoenixville 1
Pingdingshan 1
Pomigliano d'Arco 1
Princeton 1
Redmond 1
Santa Clara 1
St Petersburg 1
Tappahannock 1
Toronto 1
Wilmington 1
Woodbridge 1
Xi'an 1
Zurich 1
Totale 234
Nome #
Combinatorial control of Spo11 alternative splicing by modulation of RNA polymerase II dynamics and splicing factor recruitment during meiosis 68
The androgen receptor couples promoter recruitment of RNA processing factors to regulation of alternative polyadenylation at the 3' end of transcripts 57
MYC up-regulation confers vulnerability to dual inhibition of CDK12 and CDK13 in high-risk Group 3 medulloblastoma 47
The transcriptional terminator XRN2 and the RNA-binding protein Sam68 link alternative polyadenylation to cell cycle progression in prostate cancer 38
Dual inhibition of CDK12 and CDK13 uncovers actionable vulnerabilities in patient-derived ovarian cancer organoids 28
The DNA/RNA helicase DHX9 contributes to the transcriptional program of the androgen receptor in prostate cancer 26
An alternative splicing signature defines the basal-like phenotype and predicts worse clinical outcome in pancreatic cancer 18
CDK12/13 promote splicing of proximal introns by enhancing the interaction between RNA polymerase II and the splicing factor SF3B1 14
Transient splicing inhibition causes persistent DNA damage and chemotherapy vulnerability in triple-negative breast cancer 9
Totale 305
Categoria #
all - tutte 2.051
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.051


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20209 0 0 0 0 0 0 0 0 0 0 7 2
2020/20213 3 0 0 0 0 0 0 0 0 0 0 0
2021/20229 0 0 0 1 2 0 1 0 0 1 1 3
2022/202374 4 4 1 5 15 16 9 4 6 6 3 1
2023/2024138 2 15 0 18 12 10 11 4 5 9 36 16
2024/202572 6 2 24 32 8 0 0 0 0 0 0 0
Totale 305